Morningstar
•
May 11, 2026
Medtronic plc: Medtronic Set for Key New Product Adoption in 2026
Summary
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Bristol-Myers Squibb Company
May 12, 2026
•
BMY
Analyst Report: Stryker Corp
May 12, 2026
•
SYK
Market Digest: NOV, SYK, PPC, ABNB, RDDT
May 12, 2026
•
PPC, NOV, RDDT, SYK, ABNB
Daily – Vickers Top Buyers & Sellers for 05/12/2026
May 12, 2026
•
CVS, VECO, ACEL, LMAT, OLED, MPWR, PSN, PLSE, DVA, ATEC
Analyst Report: Boston Scientific Corporation
May 08, 2026
•
BSX
Analyst Profile
Debbie S. Wang
Senior Equity Analyst
Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device industry. Previously, she was an associate director of equity analysis for Morningstar, leading the healthcare team.Before joining Morningstar in 2002, Wang was a vice president and senior brand strategist for Leo Burnett. During her tenure at Leo Burnett, she led brand strategy on a variety of accounts, including Allstate, Amoco, McDonald/s, Heinz, Smucker’s, Pepto-Bismol, and Celebrex.Wang holds a bachelor’s degree in anthropology from Colgate University and a master’s degree in business administration from the University of Chicago Booth School of Business.
